Dane, Faysal <br/><br/>
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.  [electronic resource] 

 -  BMJ open  03 2020 
 - e027665 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-6055 
<br/><br/><label>Standard No.: </label>10.1136/bmjopen-2018-027665  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Phenylurea Compounds--therapeutic use<br/>Pyridines--therapeutic use<br/>Treatment Outcome<br/>Turkey